Recombinant microorganisms having a methanol elongation cycle (MEC)
US-9518278-B2 · Dec 13, 2016 · US
US2019352680A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2019352680-A1 |
| Application number | US-201716475409-A |
| Country | US |
| Kind code | A1 |
| Filing date | Dec 6, 2017 |
| Priority date | Jan 3, 2017 |
| Publication date | Nov 21, 2019 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to heme iron not derived from porcine blood and a method of preparing the same, and more particularly to a method of biologically preparing heme iron not derived from porcine blood, a method of preparing a salt thereof, and an iron supplement containing the salt thus prepared as an active ingredient.
Opening claim text (preview).
1 . A method of biologically preparing a salt of heme iron of Chemical Formula 1 below, not derived from porcine blood and containing no animal component, the method comprising: A) producing heme iron by culturing Escherichia coli DH5α pLEX_HMD (Accession number: KCTC 13173BP) at 39 to 44° C. and a pH of 7 to 9 in a medium containing no animal component; B) purifying the heme iron produced in step A); and C) preparing a salt of the heme iron purified in step B). 2 . The method of claim 1 , wherein the medium includes plant-derived peptone and a yeast extract prepared from yeast cultured in a plant-derived medium. 3 . The method of claim 1 , wherein the pH is adjusted using succinic acid. 4 . The method of claim 1 , wherein step B) is performed through filtration process using diatomaceous earth. 5 . The method of claim 4 , wherein the diatomaceous earth is Celite®545. 6 . A salt of heme iron of Chemical Formula 1 below not derived from porcine blood and containing no animal component, prepared by the method of claim 1 . 7 . A pharmaceutical composition for preventing or treating iron-deficiency anemia, containing the salt of heme iron of claim 6 as an active ingredient, without containing an animal component.
in which the condensed system contains four or more hetero rings · CPC title
Preparation of organic compounds containing a metal or atom other than H, N, C, O, S or halogen {(phosphoglycerides, C12P7/6481)} · CPC title
Iron; Compounds thereof · CPC title
Bacteria; Culture media therefor · CPC title
Iron compounds · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.